| Net income | 25.82M |
| Amortization of feature film production assets | |
| Revaluation of warrants | |
| Depreciation and amortization | 21.48M |
| Realized gains on sale of investments | |
| Amortization of investment income | |
| Stock compensation costs | 15.56M |
| Recovery from doubtful accounts | -410K |
| Provision for inventory obsolescence | |
| Benefit from deferred income taxes | 11.17M |
| Excess tax benefits from stock-based payment arrangements | |
| Accounts receivable | -4.91M |
| Inventory | -1.77M |
| Prepaid expenses and other assets | -19.95M |
| Feature film production assets | |
| Accounts payable | |
| Accrued expenses and other liabilities | |
| Deferred income | -2.4M |
| Net cash provided by operating activities | |
| Purchases of property and equipment and other assets | |
| Proceeds from infrastructure incentives | |
| Purchase of short-term investments | 0 |
| Proceeds from sales or maturities of investments | |
| Net cash used in investing activities | |
| Repayments of long-term debt | -13.32M |
| Dividends paid | |
| Issuance of stock, net | 1.29M |
| Proceeds from exercise of stock options | |
| Excess tax benefits from stock-based payment arrangements | 892K |
| Net cash used in financing activities | |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | -26.56M |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 38.02M |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 11.46M |